Evidence map›Paper›PMID 30379922›Full record

ArticlePloS one2018

Leptin gene variants and colorectal cancer risk: Sex-specific associations.

Kelsey A Chun, Jonathan M Kocarnik, Sheetal S Hardikar, Jamaica R Robinson, Sonja I Berndt, Andrew T Chan, Jane C Figueiredo, Noralane M Lindor, Mingyang Song, Robert E Schoen and 9 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Obesity-Associated Colorectal Cancer.International journal of molecular sciences · 2024
    Review
  4. Article
  5. Article
  6. Sex-Specific Associations between Adiponectin and Leptin Signaling and Pancreatic Cancer Survival.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 12 institutions in 2 countries.

Kelsey A ChunPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.ORCID 0000-0002-0654-3992
Jonathan M KocarnikPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.
Sheetal S HardikarPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.
Jamaica R RobinsonPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.
Sonja I BerndtDivision of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, MD, United States of America.
Andrew T ChanDivision of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Cambridge, MA, United States of America.
Jane C FigueiredoDepartment of Preventive Medicine, University of Southern California, Los Angeles, CA, United States of America.
Noralane M LindorDepartment of Health Sciences Research, Mayo Clinic, Scottsdale, AZ, United States of America.
Mingyang SongDivision of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Cambridge, MA, United States of America.
Robert E SchoenDivision of Gastroenterology, Hepatology, and Nutrition, University of Pittsburgh, Pittsburgh, PA, United States of America.
Richard B HayesDivision of Epidemiology, Department of Population Health, New York University School of Medicine, New York, NY, United States of America.
John D PotterPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.
Rami NassirDepartment of Biochemistry and Molecular Medicine, University of California-Davis, Davis, CA, United States of America.
Stéphane BézieauService de Génétique Médicale, Université de Nantes, Nantes, France.
Loic Le MarchandEpidemiology Program, University of Hawai'i Cancer Center, Honolulu, HI, United States of America.
Martha L SlatteryDepartment of Internal Medicine, University of Utah Health Sciences Center, Salt Lake City, UT, United States of America.
Emily WhitePublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.
Ulrike PetersPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.
Polly A NewcombPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.
University of Washington · USHarvard University · USUniversity of Utah · USFred Hutch Cancer Center · USGénétique Médicale & Génomique Fonctionelle · FRMayo Clinic in Arizona · USNational Cancer Institute · USNew York University · USUniversity of California, Davis · USUniversity of Hawaiʻi at Mānoa · USUniversity of Pittsburgh · USUniversity of Southern California · US

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Marian Esvelt · 1985 to 2026
$296.4M
Molecular pathological epidemiology of colorectal cancerU01CA137088 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PETERS, ULRIKE · 2009 to 2018
$21.8M
Data sharing: the Colon Cancer Family Registry CohortU01CA167551 · NCI · UNIVERSITY OF MELBOURNE · PI Daniel David BUCHANAN, Steven Gallinger · 2018 to 2026
$16.8M
SEATTLE FAMILIAL COLORECTAL CANCER REGISTRYU01CA074794 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI NEWCOMB, POLLY A · 1997 to 2007
$14.1M
Institute of Translational Health SciencesKL2TR000421 · NCATS · UNIVERSITY OF WASHINGTON · PI DISIS, MARY L. · 2012 to 2016
$12.6M
Genome-Wide Association Study of Nonsynonymous SNPs in Colon CancerR01CA059045 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PETERS, ULRIKE · 1994 to 2011
$11.5M
The Colon Cancer Family Registry: SeattleU24CA074794 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI NEWCOMB, POLLY A · 2008 to 2011
$7.0M
Contributing Factors and Consequences of Cancer Health DisparitiesT32CA094880 · NCI · UNIVERSITY OF WASHINGTON · PI Christopher I Li, AMANDA IRENE PHIPPS · 2017 to 2026
$3.7M
Training and Research in Colon Cancer SurvivalK05CA152715 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI NEWCOMB, POLLY A · 2010 to 2019
$991k
Diabetes, Medications and the Cost-Effectiveness of Screening for Colorectal NeoplasiaK07CA222060 · NCI · UNIVERSITY OF UTAH · PI HARDIKAR, SHEETAL · 2018 to 2022
$791k
FHCRC High-Performance Computing ClusterS10OD020069 · OD · FRED HUTCHINSON CANCER RESEARCH CENTER · PI KOOPERBERG, CHARLES L · 2015 to 2015
$600k
NCATS NIH HHS KL2 TR000421NCI NIH HHS K05 CA152715NCI NIH HHS K07 CA222060NCI NIH HHS P30 CA015704NCI NIH HHS R01 CA059045NCI NIH HHS T32 CA094880NCI NIH HHS U01 CA074794NCI NIH HHS U01 CA137088NCI NIH HHS U01 CA167551NCI NIH HHS U24 CA074794NIH HHS S10 OD020069
6 · The paper itself

Abstract

backgroundHigh levels of serum leptin and low levels of serum adiponectin are strongly correlated with obesity, a well-established risk factor for colorectal cancer (CRC). Growing evidence suggests that dysregulation of leptin and adiponectin levels may play an etiological role in colorectal carcinogenesis. We evaluated 20 candidate variants in 4 genes previously shown to alter serum leptin and adiponectin levels for associations with obesity (BMI>30 kg/m2) and CRC risk.

methodsWe analyzed 6,246 CRC cases and 7,714 population-based controls from 11 studies within the Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO). Associations of each variant with obesity or CRC were evaluated using multivariate logistic regression models stratified by sex and adjusted for age, a study variable, and the first three principal components of genetic ancestry. Gene-specific False Discovery Rate (FDR)-adjusted p-values <0.05 denoted statistical significance.

resultsTwo variants in the leptin gene showed statistically significant associations with CRC among women: LEP rs2167270 (OR = 1.13, 95% CI: 1.06-1.21) and LEP rs4731426 (OR = 1.09, 95% CI: 1.02-1.17). These associations remained significant after adjustment for obesity, suggesting that leptin SNPs may influence CRC risk independent of obesity. We observed statistically significant interactions of the leptin variants with hormone replacement therapy (HRT) for CRC risk; these variant associations were strengthened when analyses were restricted to post-menopausal women with low estrogen exposure, as estimated by 'never use' of HRT and/or non-obese BMI. No variants were associated with CRC among men.

conclusionsLeptin gene variants may exhibit sex-specific associations with CRC risk. Endogenous and exogenous estrogen exposure may modify the association between these variants, leptin levels, and CRC risk.

Indexed as

Genetic Predisposition to DiseasePolymorphism, Single NucleotideAdiponectinAdultAgedAged, 80 and overBody Mass IndexColorectal NeoplasmsFemaleGenetic Association StudiesGenotypeHumansLeptinMaleMiddle AgedSex FactorsAdiponectinADIPOQ protein, humanLeptin

Identifiers

PMID30379922
PMCPMC6209341
OpenAlexW2899186366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.